Sign In
Buy BNR
$8.90
+0.0500 (+0.565%)
At Close: Jul 31, 2026
Week In Review: LianBio Acquires 2 IBD Candidates In $218 Million Deal
11:15pm, Sunday, 23'rd May 2021
LianBio, a Princeton-Shanghai company, in-licensed Greater China rights for two inflammatory bowel disease candidates from Landos Biopharma. Ji Xing Pharma of Shanghai acquired Greater China rights to
Pharmaron, I-Mab And Burning Rock Get Investor Validation From MSCI
06:38pm, Friday, 21'st May 2021
MSCI's addition of Pharmaron, I-Mab and Burning Rock to its China All Shares Index highlights their strong growth potential. Inclusion typically represents validation for a company's products and outl
Burning Rock Announces the Launch of China's First Prospective Pan-Cancer Multi-omics Early Detection Study
05:06am, Wednesday, 19'th May 2021
BEIJING, May 19, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced the launch of the PRESCIENT (Pan-canceR Early-Stage deteCt
Burning Rock to be Added to MSCI China Index
04:00am, Wednesday, 12'th May 2021
GUANGZHOU, China, May 12, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequenci
Burning Rock Schedules First Quarter of 2021 Earnings Release on May 25, 2021
10:00pm, Wednesday, 28'th Apr 2021
GUANGZHOU, China, April 28, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequen
GUANGZHOU, China, April 13, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that its liquid biopsy assay has achieved stron
Burning Rock Biotech Limited (BNR) CEO Yusheng Han on Q4 2020 Results - Earnings Call Transcript
02:50pm, Thursday, 11'th Mar 2021
Burning Rock Biotech Limited (BNR) CEO Yusheng Han on Q4 2020 Results - Earnings Call Transcript
Burning Rock Reports Fourth Quarter and Full Year 2020 Financial Results
07:00pm, Wednesday, 10'th Mar 2021
GUANGZHOU, China, March 10, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequen
Burning Rock Announces Preliminary Fourth Quarter and Full Year 2020 Results and Schedules Earnings Release on March 11, 2021
08:00pm, Monday, 08'th Feb 2021
GUANGZHOU, China, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequenc
Burning Rock (BNR) in Focus: Stock Moves 5.4% Higher
09:02am, Friday, 22'nd Jan 2021
Burning Rock (BNR) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Burning Rock Biotech Expands Test Portfolio In Bid For Growth
05:20pm, Wednesday, 30'th Dec 2020
Burning Rock Biotech went public in the U.S. in June 2020. The firm provides a range of early detection and therapy selection testing services in China.
OCX Stock: Why Shares of Biotech OncoCyte Are Skyrocketing Today
11:21am, Tuesday, 15'th Dec 2020
Shares of OCX stock are blasting off on Tuesday morning after a major company agreement with an important China-based biotech firm. The post OCX Stock: Why Shares of Biotech OncoCyte Are Skyrocketing
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 19)
10X Genomics Inc (NASDAQ: TXG)
ALX Oncology Holdings Inc (NASDAQ: ALXO)
Avenue Therapeutics Inc (NASDAQ: ATXI)...
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 17)
Catalent Inc (NYSE: CTLT)
CureVac N.V. (NASDAQ: CVAC) (follow-on buying after a 250% advance on its debut Friday...
Burning Rock Reports Second Quarter 2020 Financial Results
04:38am, Tuesday, 11'th Aug 2020
GUANGZHOU, China, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequenc
